Growing Up in Singapore Towards Healthy Outcomes (GUSTO)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01174875|
Recruitment Status : Active, not recruiting
First Posted : August 4, 2010
Last Update Posted : January 23, 2023
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
This study aims to test the following hypotheses in women recruited in early pregnancy and whose children will be followed up till at least 14 years of age.
- Epigenetic changes in conceptual tissues obtained at birth reflect the environment that the fetus was exposed to during development.
- The pattern of epigenetic marks in gene promoters obtained from DNA in birth tissues, together with genotype, phenotype, and environmental exposures, can be utilized to assess how the perinatal environment affects subsequent metabolic, neurodevelopmental and other phenotypes.
|Condition or disease|
|Metabolic Diseases Neurological and Mental Health Conditions|
The dramatic emergence of non-communicable diseases (NCDs) in Asia has coincided with the rapid socioeconomic and nutritional transition taking place in the region, with the prevalence of diabetes rising five-fold in Singapore in less than four decades. One unique aspect of the epidemic has been the significant ethnic differences in predisposition to diabetes among Asians and in the ethnic variation between BMI and the risk of developing insulin resistance, a precursor to type 2 diabetes. Apart from genetic factors, dietary, lifestyle and cultural factors might have influenced the developmental programming through effects on the mechanisms associated with developmental plasticity. A center piece of this study is to examine how epigenetic changes at birth both reflects past developmental influences and, in association with other factors, influences future trajectories of development and its relationship to NCDs. Also factors active during childhood - especially the first 1000 days of life - will be focused upon.
The longitudinal GUSTO birth cohort study allows us to examine associations among genetic, environmental and lifestyle interactions in the three distinct ethnic groups, Chinese, Malays and Indians, present in the Singaporean population.
Participants have been followed up for their pregnancy outcome, fetal growth and offspring development for over a decade. Participants will continue to be followed up as the children enter into the pubertal phase from the age of 10 to 14 years.
Data will be collected through questionnaires and clinical measurements. The questionnaires include socio-economic factors, maternal and child's diet, medical histories, behavioural, cognition, lifestyle factors, health status, and home environment. Bio-physical measurements will be obtained from anthropometric measurements of participants, human biological materials such as blood, buccal swabs, saliva, hair, urine, stool, oral specimen such as exfoliated milk teeth, dental plaque and tongue biofilms are collected from the participants (mother / father / child where applicable) at their follow-up time points with the GUSTO cohort upon their consent.
|Study Type :||Observational|
|Actual Enrollment :||1247 participants|
|Official Title:||Metabolic Health in Asian Women and Their Children|
|Actual Study Start Date :||June 2009|
|Estimated Primary Completion Date :||July 2029|
|Estimated Study Completion Date :||July 2029|
Pregnant mothers, infants and children
Women in their early pregnancy who are attending the first trimester antenatal ultrasound scan at the public maternity units at KK Women's and Children's Hospital (KKH) and National University Hospital (NUH). Only women age 18 years and above who are Singapore Citizens or Singapore Permanent Residents. Participants have to intend to eventually deliver in NUH or KKH and to reside in Singapore for the next 5 years. Willingness to donate cord, cord blood and placenta. The fetus should be racially homogenous with both sets of grandparents of the same ethnicity. Babies born from these mothers will be followed up until the child is at least 14 years of age.
- Roles of fetal, developmental and epigenetic factors in pathways to disease [ Time Frame: Perinatal ]To evaluate the role of fixed genetic risk variants, modifiable epigenetic markers, circulating metabolites and hormones in blood, and host-microbe interactions which can reflect past developmental influences, and in association with other factors, affect future trajectories of development and its relationship to NCDs.
- Influence of prenatal and early postnatal factors on child health [ Time Frame: During pregnancy and infancy period ]To examine the role of maternal nutrition, lifestyle, emotional health, and other environmental factors in infancy that can influence the development of phenotypes in childhood which confer risk for later metabolic and mental disorders.
- Effect of factors in pregnancy and early postpartum period on maternal health [ Time Frame: During pregnancy and postpartum period ]To examine the role of maternal nutrition, lifestyle, emotional health, and other environmental factors in pregnancy or postpartum period that can influence future maternal risk of metabolic disorders, including body weight changes.
- Influence genetic and epigenetics factors in combination with lifestyle on child health [ Time Frame: Childhood and Adolescence up to age 14 ]To examine the role of genetic and epigenetic factors, lifestyle (physical activity and dietary intake), growth trajectories and other environmental factors that can influence the development of phenotypes in childhood which confer risk for later metabolic and mental disorders.
Biospecimen Retention: Samples With DNA
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||18 Years to 50 Years (Adult)|
|Sexes Eligible for Study:||Female|
|Accepts Healthy Volunteers:||Yes|
|Sampling Method:||Non-Probability Sample|
- Women 18 years and above
- Pregnant women attending the first visit (< 14 weeks GA) at the maternity units of KKH and NUH
- Singapore citizens or Singapore Permanent Residents
- Currently resident in mainland Singapore
- Intention to eventually deliver in KKH or NUH
- Intention to reside in Singapore for the next 5 years
- Intention to donate cord, cord blood and placenta
- The fetus should be racially homogenous with both sets of grandparents of the same ethnicity
- Women whose pregnancies end in miscarriages will be excluded
- Pregnant women on chemotherapy
- Exclude women with significant medical conditions e.g. Type 1 diabetes mellitus, psychosis etc.
- Exclude women on certain medications - e.g. psychotropic drugs.
- Mixed marriages will be excluded
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01174875
|National University Hospital|
|Principal Investigator:||Yap-Seng Chong||National University Health System|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
|Responsible Party:||National University Hospital, Singapore|
|Other Study ID Numbers:||
NMRC/TCR/004-NUS/2008 ( Other Grant/Funding Number: National Medical Research Council )
NMRC/TCR/012-NUHS/2014 ( Other Grant/Funding Number: National Medical Research Council )
MOH-000504 ( Other Grant/Funding Number: National Medical Research Council )
|First Posted:||August 4, 2010 Key Record Dates|
|Last Update Posted:||January 23, 2023|
|Last Verified:||January 2023|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||No|